Press Release: 20th Anniversary Pharmaceutical and Medical Device Compliance Congress Offers Half-Day, Invitation-Only CCO Roundtable Featuring Sally Molloy, JD, Acting Chief, Strategy, Policy & Training Unit, DOJ Fraud Section
  • Sponsored by the Pharmaceutical Compliance Forum
  • November 6 - 8, 2019
  • Onsite at the Mandarin Oriental, Washington, DC
  • Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
  • Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com
REGISTER NOW
For Congress registration information, visit www.pharmacongress.com/registration/, email registration@hcconferences.com,
or call 800-503-7419.

SPEAKER PRESENTATION PROPOSALS
Proposals May Be Submitted Through Our Online Form
- Click Here -
FEATURING INVITATION-ONLY:
CHIEF COMPLIANCE OFFICER ROUNDTABLE
(Jointly Sponsored by PCF and PhRMA; Special 11/6 Morning Session, Invitation-only)
FEATURING

Sally Molloy, JD
Acting Chief, Strategy, Policy & Training Unit, Fraud Section, Former Assistant U.S. Attorney,
US Attorney's Office, Northern District of Georgia, US Department of Justice, Washington, DC

WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- AUGUST 1, 2019: The 20th Anniversary Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, will be held November 6 - 8, 2019 at the Mandarin Oriental in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).

KEYNOTE SPEAKERS

Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD

Brian Allen Benczkowski, JD
Assistant Attorney General, Criminal Division, US Department of Justice, Principal Deputy Assistant Attorney General for Legislative Affairs Former Republican Staff Director, Committee on the Judiciary, US Senate Former Staff, Senator Pete Domenici and Representative Jim Sensenbrenner, Washington, DC

Susan Dentzer
Visiting Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC

Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan, Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC

James Sheehan, JD
Chief, Charities Bureau at Attorney General of New York, Former Chief Integrity Officer, Executive Deputy Commissioner, City of New York Human Resources Administration, Former, NY Medicaid Inspector General, Former Associate United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, New York, NY

AND A FRIDAY, NOVEMBER 8 INDUSTRY-ONLY
BEST PRACTICES ROUNDTABLE
(Industry-only session for pharma and medical device compliance
professionals and in-house counsel only)
FEATURING

Jacob T. Elberg, JD
Associate Professor of Law, Seton Hall Law School, Former Chief, Health Care & Government, Fraud Unit and Assistant US Attorney, US Attorney's Office, District of New Jersey, US, Department of Justice, Newark, NJ

FEATURED FACULTY

Yogesh Bahl, CPA, MBA
Managing Director, Alix Partners, New York, NY

Ann E. Beasley, JD
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA

Thomas Beimers, JD
Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, Former Special Assistant United States Attorney, US Attorney's Office, Eastern District of Michigan, Minneapolis, MN and Washington, DC

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC

Ela Bochenek, JD
Vice President and Chief Compliance Officer, Nabriva Therapeutics PLC, Former Assistant Dean Graduate & Professional Education, Seton Hall University School of Law, King of Prussia, PA

Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

Kathleen M. Boozang, JD, LLM
Dean and Professor of Law, Seton Hall University School of Law, Newark, NJ

Christie Camelio
Vice President, Deputy Global Chief Compliance Officer, Celgene, Former Executive Director, Head of Risk Management Center of Excellence, Novartis Pharmaceuticals, Florham Park, NJ

Jennifer Chillas, JD
Senior Corporate Counsel, Bristol-Myers Squibb, New York, NY

Brian Conner
Chief Compliance Officer, Strongbridge Biopharma plc, Former Assistant Compliance Officer of the Americas, Shire, Feasterville Trevose, PA

Thomas Costa, JD
Member, US Board of Directors, Sanofi, Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC

Kris Curry, MBA
Principal, Assurance Services, EY, Former Vice President, Global Chief Compliance Officer, Pharma Sector, Johnson & Johnson, Philadelphia, PA

Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL

Charlene E. Davis, JD
Associate Vice President & Head of Healthcare Compliance North America, Sun Pharmaceutical Industries, Princeton, NJ

CJ DeKreek, MBA
Senior Director, Ankura, Atlanta, GA

Julie DeLong, CFA
Senior Managing Director, Ankura Consulting Group, LLC, Atlanta, GA

Gary Del Vecchio
Health Care Compliance Officer Cardiovascular & Metabolism and Puerto Rico, The Janssen Pharmaceutical Companies of Johnson & Johnson; Former Executive Director, US Pharmaceutical Compliance and Ethics, Bristol-Myers Squibb, Pennington, NJ

Sarah diFrancesca, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY

Christian A. Dingler
Associate Director, Navigant, Life Sciences, Richmond, VA

Stefanie A. Doebler, JD
Of Counsel, Covington & Burling LLP, Washington, DC

Adam Dubow, JD
Global Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ

Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Purdue Pharma LP, Former Member, PCF Executive Committee, Stamford, CN

Alison Fethke, JD
Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL

Sarah A. Franklin, JD
Partner, and Vice-chair, Life Sciences Litigation and Investigations Practice Group, Covington & Burling LLP, Former Attorney, Bureau of Consumer Protection, Division of Marketing Practices, Federal Trade Commission, Washington

Nereyda Garcia, JD
Global Head, Ethics and Compliance, Alnylam Pharmaceuticals, Cambridge, MA

Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY

Virginia "Ginny" A. Gibson, JD
Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

Jonathan Glazier, MBA, JD
Head of Legal Compliance, Philips North America, Former Sr Director of Corporate Compliance and Privacy Officer, Fresenius Medical Care North America, Andover, MA

Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY

Kimi Gorman, CCEP, CFE
Director, Ethics & Compliance, Novo Nordisk Inc., Former Compliance Manager, B. Braun Medical, Princeton, NJ

Amy Greenstein, JD/MSFS
Associate Principal, IQVIA, Boston, MA

Nancy Grygiel, JD
Vice President, Worldwide Compliance & Business Ethics, Amgen, Former Senior Director, Global Compliance, Mylan, Newbury Park, CA

Rachael (Hill) Honig, JD
First Assistant US Attorney, US Attorney's Office, District of New Jersey, US Department of Justice, Former Corporate Counsel, Litigation, Celgene, New York, NY

Casey J. Horton, CFE
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL

Darren R. Jones, CIA
Senior Principal, Commercial Compliance, Global Consulting Practice Leader, IQVIA, New York, NY

Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Richard Liner, JD, MPH
Senior Counsel, Compliance & Investigations, Bayer Healthcare, Whippany, NJ

Carrie Sarhangi Love, JD
Litigation Partner, Armstrong Teasdale LLP; Former Assistant District Attorney, Philadelphia; Philadelphia, PA

Jill Fallows Macaluso, JD, RN
Corporate Vice President, Chief Ethics & Compliance Officer, Novo Nordisk Inc., Princeton, NJ

Susan Markel
Managing Director, Alix Partners, Former Chief Accountant, Division of Enforcement, US Securities and Exchange Commission, Washington DC

Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Ridgefield, C

Heather McCollum, JD, MHA, CCEP-I
Director Compliance, Shionogi Inc., Florham Park, NJ

William A. McConagha, JD
Partner, Sidley Austin, LLP, Former Health Policy Advisor, Health, Education, Labor and Pensions Committee, US Senate, Former Assistant Commissioner, US Food and Drug Administration, Washington, DC

Jenny McVey, PhD
Compliance Risk & Mitigation, Novo Nordisk, Inc., Former Compliance Officer, Hands International, Princeton, NJ

Gregory S. Moss, JD
Senior Vice President, Deputy General Counsel, Kadmon Corporation, LLC, New York, NY

Kamleh J. Nicola, LLB
Partner, Baker & McKenzie LLP, Toronto, Canada

Katherine Norris, MPA
Director, Corporate Compliance & Risk Management, Berkeley Research Group LLC, Washington, DC

Dan O'Connor
Senior Vice President, PharmaCertify, a Division of NXLevel Solutions, New York, NY

Michael O'Connor
Vice President of Compliance Technology, Porzio Life Sciences, LLC, Former Global Head Compliance and Ethics Operations, Alexion, Former Executive Director, Global Head, IS Business Consulting, Boehringer Ingelheim, New York, NY

Amy Pawloski, CPA, PMP, CCEP
Compliance Officer-Operations, Endo Pharmaceuticals; Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA

Erica Powers
Director, Compliance Operations, Sage Therapeutics, Former Director Corporate Compliance, Vertex, Cambridge, MA

Arjun Rajaratnam, JD, MS
Chief Compliance Officer, Smith & Nephew; Former Compliance Officer, US Pharmaceuticals, GlaxoSmithKline; Former Member, PCF Executive Committee; Raleigh, NC

Sunitha Ramamurthy, JD
Head of Compliance, Loxo Oncology, wholly owned subsidiary of Eli Lilly; Former Executive Director, Office of Ethics and Compliance, Boehringer Ingelheim Pharmaceuticals; Stamford, CT

Kristin Rand, JD, MA
Vice President and Compliance Officer, Seattle Genetics, Former Compliance Director, Policy, Ethics, Training & Communication, Genentech, New York, NY

Marc Stephen Raspanti, JD
Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP, Philadelphia, PA

Kelly N. "Nikki" Reeves, MPA, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding LLP, Washington, DC

Lesley C. Reynolds, JD
Partner, Life Sciences Health Industry Group, Reed Smith, Washington, DC

Angela Rodin, MBA
Principal, KPMG, Former Vice President, Global Head of Investigations and Monitoring, GlaxoSmithKline Pharma GmbH, Washington, DC

Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA

Amanda Masselam Strachan, JD
Assistant US Attorney and Chief, Health Care Fraud Unit, US Attorney's Office, District of Massachusetts, US Attorney's Office, US Department of Justice, Boston, MA

Ann-Marie Tejcek, MA
Senior Director North American Ethics & Compliance Officer, Eli Lilly and Company, Indianapolis, IN

Manny Tzavlakis
Managing Partner, Helio Health, Morristown, NJ

Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS; Washington, DC

Elizabeth Weiss, JD
Assistant General Counsel; Chief Compliance Counsel, Pfizer, Peapack, NJ

Caroline West, JD
Global Chief Compliance Officer, Olympus Corporation, Former Sr. VP , Chief Compliance and Risk Officer, Shire, Former VP Global Legal Compliance, Aventis, Philadelphia, PA

Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC; Editor, Life Science Compliance Update; Senior Fellow & Adjunct Professor, Life Sciences Compliance at Mitchell Hamline School of Law, West Chester, PA

Jonathan Wilkenfeld, MBA
Partner, Potomac River Partners, Washington, DC

Susan Williamson, MBA, CPA
Senior Vice President & Chief Compliance Officer, Endo Pharmaceuticals, Former Senior Manager, WBB Finance, Operational Risk Management, Pfizer, Philadelphia, PA

Susan Winkler, JD
Partner, Pierce Bainbridge Beck Price & Hecht LLP, Former Assistant US Attorney and Head, Health Care Fraud Unit, US Attorney's Office for the District of Massachusetts, Boston, MA

THE 2018 NINETEENTH ANNUAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE IN VARIOUS POST CONFERENCE FORMATS

The Nineeenth Annual Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months).

YOU CAN PURCHASE JUST THE NINETEENTH ANNUAL PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of the 2018 Nineeenth Annual Pharma Congress Presentations!
$195

Order Now

Flash Drive of the 2018 Nineeenth Annual Pharma Congress Presentations!
$195
Order Now


PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE

Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction.

LIVE AND ARCHIVED WEBCAST PARTICIPATION

Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office.

WEBCAST INTERFACE SAMPLE

Click here for a sample stream


2019-2020 GLOBAL PHARMA COMPLIANCE CONGRESSES

TWENTIETH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November 6 - 8, 2019
Mandarin Oriental, Washington, DC
www.PharmaCongress.com
FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
April 2020
Location to be announced
www.International PharmaCongress.com
NINTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Policy & Medicine Compliance Update
Spring 2020
Shanghai, China
www.Asian PharmaCongress.com

SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 70+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.


CO CHAIRS

Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ (PCF Secretary)


Jeffrey Kawalek, MBA
Deputy Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Philadelphia, PA (PCF Chair)


Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD (PCF Treasurer)


Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ (PCF Co-Chair)


Donna White, CCEP
Vice President, Contracts & Compliance, Chiesi, USA, Cary, NC (PCF Co-Chair)


Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, Parsippany, NJ (PCF Co-Chair)

REMEMBER THE FIRST PHARMA CONGRESS


GRANTORS:
GOLD


SILVER




BRONZE
Sponsor of Pharma Congress

Sponsor of Pharma Congress







Sponsor of Pharma Congress

Sponsor of Pharma Congress

































MEDIA PARTNERS:








STAY CONNECTED


Tweet using #PharmaCongress

PHARMA CONGRESS IS
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul


2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid


2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila



2016 - Warsaw


2017 - Lisbon


2018 - Vienna

CONGRESS REGISTRATION
For Congress registration information, visit https://www.pharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information visit https://www.pharmacongress.com/promotional-opportunities/, or contact Justin Sorensen, Exhibit Manager, 206-452-0609 phone, 206-319-5303 fax, exhibits@hcconferences.com.